Funding and Support

FDA Broad Agency Announcement for the Advanced Research and Development of Regulatory Science

The U.S. Food and Drug Administration has an open, continuing announcement to solicit research and development in support of regulatory science and innovation. The Safe Use Initiative welcomes proposals to this announcement which support its mission and goal.

8.5 Studies to increase the safety of post approval drug use" "Develop innovative methods to better understand and reduce the occurrence of adverse events in post market use of drugs. Examples include but not limited to hypoglycemia in certain patient populations, serious bleeding in patients on anticoagulants, and patients in chronic pain on opioid therapy. Approaches could include the use of innovative messaging strategies, electronic health records, mobile technologies, clinical studies, or educational campaigns.

Contact FDA

Safe Use Initiative Team

Professional Affairs and Stakeholder Engagement (PASE)

Office of the Center Director

WO 51-2341

10903 New Hampshire Avenue

Silver Spring, MD 20993

Page Last Updated: 09/19/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.